Australian Clinical Labs Limited (ASX:ACL)
Australia · Delayed Price · Currency is AUD 2.820
+0.020 (0.71%)
Dec 4, 2025, 3:44 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 541.06 million as of December 3, 2025. Its market cap has decreased by -21.71% in one year.
Market Cap
541.06M
Enterprise Value
809.94M
Revenue
741.27M
Ranking
n/a
PE Ratio
16.42
Stock Price
2.82
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 541.06M, a decrease of -21.62%. That is a compound annual growth rate of -5.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 541.06M | -20.96% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
| May 14, 2021 | 690.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.56B |
| Pro Medicus | 27.16B |
| Cochlear | 17.94B |
| Sonic Healthcare | 11.43B |
| Ramsay Health Care | 8.64B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.89B |
| Mesoblast | 3.23B |